Who are NeuroSpectrum Insights's competitors?

NeuroSpectrum Insights's key competitors include GE HealthCare, Aclarion, Inc. Common Stock, Hyperfine, Inc. Class A Common Stock, and others. These companies compete in similar markets and product categories.

Who does NeuroSpectrum Insights partner with?

NeuroSpectrum Insights's notable partners include University of Louisville Research Foundation, Norton Children’s Autism Center.

Where is NeuroSpectrum Insights headquartered?

NeuroSpectrum Insights is headquartered in United States of America.

NSI

NeuroSpectrum Insights

NSIH

Pre-IPO

NeuroSpectrum Insights has filed an S-1 registration statement with the SEC and is not yet trading. Financial statements will appear here once it begins reporting as a public company.

S-1 Filings

Registration statements filed with the SEC ahead of the planned listing

S-1/AFiled July 10, 2026

View on SEC.gov

S-1/AFiled May 5, 2026

View on SEC.gov

S-1/AFiled April 6, 2026

View on SEC.gov

S-1/AFiled January 23, 2026

View on SEC.gov

S-1/AFiled September 24, 2025

View on SEC.gov

S-1Filed June 20, 2025

View on SEC.gov

Competitors

By market cap

GE HealthCare Technologies$29.4B-13.8%

Alto Neuroscience$970.0M+1,471%

Hyperfine, Inc.$111.7M+87.5%

Aclarion, Inc.$7.2M+58.8%

NSI

NeuroSpectrum Insights-—

By revenue growth

Hyperfine, Inc.+30.7%

GE HealthCare Technologies+6.0%

By net margin

GE HealthCare Technologies9.1%-1.9pp

Hyperfine, Inc.-226.88%+117pp

Profile

NeuroSpectrum Insights, Inc. is a medical technology company specializing in the commercialization of computerized analysis software for the diagnosis of neurological and neurodevelopmental disorders. The company's core value proposition is providing clinicians with objective, automated brain structural markers to reduce diagnostic lead times and enable earlier intervention for conditions like autism. Their proprietary technology leverages advanced algorithms to analyze standard MRI scans, replacing subjective behavioral assessments with precise, data-driven measurements.

Competitive position

NSIH holds an exclusive commercialization license for patented brain-mapping technology and has achieved FDA 510(k) clearance for its lead product.

GeographiesUnited States, Canada

Customer segmentsSpecialized Clinicians, Healthcare Providers

Business modelFee-per-test, Licensing

SuppliersUniversity research foundations, MRI hardware manufacturers, Cloud computing infrastructure

CustomersSpecialized pediatric clinicians, Hospitals, Diagnostic imaging centers, Medical insurance payers

CountryUnited States of America

SectorHealth Care

IndustryHealth Care Equipment & Supplies

FilingsSEC EDGAR

Questions, answered.

Who are NeuroSpectrum Insights's competitors?: NeuroSpectrum Insights's key competitors include GE HealthCare, Aclarion, Inc. Common Stock, Hyperfine, Inc. Class A Common Stock, and others. These companies compete in similar markets and product categories.
Who does NeuroSpectrum Insights partner with?: NeuroSpectrum Insights's notable partners include University of Louisville Research Foundation, Norton Children’s Autism Center.
Where is NeuroSpectrum Insights headquartered?: NeuroSpectrum Insights is headquartered in United States of America.